Universal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 48,714 SiBone (NASDAQ:SIBN)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in SiBone, purchasing 48,714 shares valued at approximately $683,000, which represents about 0.11% of the company at the end of the reporting period.
• SiBone recently reported a quarterly earnings per share of ($0.15), surpassing analysts' expectations of ($0.24) and demonstrating revenue of $47.29 million.
• Insider activity included significant stock sales by executives, with SVP Michael A. Pisetsky and CFO Anshul Maheshwari selling over 8,000 shares combined, reflecting a total decrease in their positions.

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in SiBone (NASDAQ:SIBN - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 48,714 shares of the company's stock, valued at approximately $683,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.11% of SiBone at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in SIBN. Silvercrest Asset Management Group LLC increased its position in SiBone by 21.9% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 1,953,806 shares of the company's stock valued at $27,392,000 after acquiring an additional 350,970 shares during the period. Victory Capital Management Inc. raised its stake in shares of SiBone by 55.0% during the 1st quarter. Victory Capital Management Inc. now owns 631,568 shares of the company's stock worth $8,861,000 after purchasing an additional 224,190 shares in the last quarter. Marshall Wace LLP lifted its holdings in shares of SiBone by 332.5% during the 4th quarter. Marshall Wace LLP now owns 264,523 shares of the company's stock valued at $3,709,000 after buying an additional 203,361 shares during the last quarter. Nuveen Asset Management LLC grew its stake in shares of SiBone by 17.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,263,988 shares of the company's stock valued at $17,721,000 after buying an additional 190,830 shares in the last quarter. Finally, Lisanti Capital Growth LLC bought a new position in SiBone during the first quarter valued at approximately $2,364,000. 98.11% of the stock is currently owned by institutional investors and hedge funds.

SiBone Trading Down 0.0%

SiBone stock traded down $0.01 during trading hours on Wednesday, reaching $16.00. 499,998 shares of the company's stock traded hands, compared to its average volume of 429,337. The company has a debt-to-equity ratio of 0.21, a quick ratio of 7.26 and a current ratio of 8.53. SiBone has a fifty-two week low of $11.70 and a fifty-two week high of $20.05. The firm has a market capitalization of $681.71 million, a price-to-earnings ratio of -28.74 and a beta of 0.91. The firm's 50 day moving average is $17.84 and its 200-day moving average is $16.63.

SiBone (NASDAQ:SIBN - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.05. SiBone had a negative return on equity of 14.28% and a negative net margin of 12.83%. The company had revenue of $48.63 million during the quarter, compared to the consensus estimate of $48.12 million. On average, analysts predict that SiBone will post -0.78 earnings per share for the current year.

Analysts Set New Price Targets

SIBN has been the subject of several recent research reports. Truist Financial boosted their target price on shares of SiBone from $20.00 to $22.00 and gave the stock a "buy" rating in a research report on Tuesday, May 6th. Cantor Fitzgerald restated an "overweight" rating and set a $25.00 target price on shares of SiBone in a report on Tuesday. Finally, Needham & Company LLC reiterated a "buy" rating and set a $24.00 price target on shares of SiBone in a research note on Tuesday, May 6th.

Insider Activity at SiBone

In related news, Director Jeffrey W. Dunn sold 3,377 shares of SiBone stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $19.05, for a total value of $64,331.85. Following the sale, the director owned 17,354 shares of the company's stock, valued at approximately $330,593.70. The trade was a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Michael A. Pisetsky sold 3,459 shares of SiBone stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $19.66, for a total value of $68,003.94. Following the completion of the sale, the senior vice president directly owned 264,636 shares in the company, valued at approximately $5,202,743.76. This represents a 1.29% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 57,925 shares of company stock worth $1,116,346. Corporate insiders own 3.90% of the company's stock.

SiBone Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.